FDA mandates safety label updates for all GLP-1 medications due to a potential increased risk of NAION, a rare eye condition causing vision loss.
News Image
News Date
News Category
FDA mandates safety label updates for all GLP-1 medications due to a potential increased risk of NAION, a rare eye condition causing vision loss.